A microenvironmental model of carcinogenesis

Nature Reviews Cancer

Volumn 8, Issue 1, 2008, Pages 56-61

  Gatenby, Robert A ^a   Gillies, Robert J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; PROTEIN P63; RAS PROTEIN; UVOMORULIN; VASCULOTROPIN;

CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MATHEMATICAL MODEL; MICROENVIRONMENT; NOTE; PRECANCER; PRIORITY JOURNAL; THEORETICAL MODEL;

CELL AGING; CELL DIVISION; EPITHELIUM; HUMANS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 37549013776     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2255     Document Type: Note

References (35)

1. Garcia, S. B., Novelli, M. & Wright, N. A. The clonal origin and clonal evolution of epithelial tumors. Int. J. Exp. Path. 81, 89-116 (2000).
2. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
3. Ilyas, M., Straub, J., Tomlinson, I. P. M. & Bodmer, W. F. Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35, 335-351 (1999).
4. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
5. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
6. Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891-899 (2004).
7. Gatenby, R. A. & Vincent, T. L. An evolutionary model of carcinogenesis. Cancer Res. 63, 6212-6220 (2003).
8. Gatenby, R. A., Vincent, T. & Gillies, R. Evolutionary dynamics in carcinogenesis. Math. Models Methods Appl. Sci. 15, 1-20 (2005).
9. Vincent, T. L. & Gatenby, R. A. Modeling cancer as an evolutionary game. Int. Game Theor. Rev. 7, 331-346 (2005).
10. Gatenby, R. et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer 97, 646-653 (2007).
11. Isakoff, S. J. et al. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res. 65, 10992-11000 (2005).
12. Derksen, P. W. B. et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449 (2006).
13. Eckert, L. B. et al. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res. 64, 4585-4592 (2004).
14. Carroll, D. K. et al. p63 regulates an adhesion program and cell survival in epithelial cells. Nature Cell Biol. 8, 551-560 (2006).
15. Hofmann, C. et al. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology 132, 587-600 (2007).
16. Ishida, H. et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci. 98, 636-643 (2007).
17. Sporn, M. B. & Roberts, A. B. Autocrine growth factors and cancer. Nature 313, 745-747 (1985).
18. Arteag, C. L. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 4, 31-39 (2002).
19. Cantley, L. C. et al. Oncogenes and signal transduction. Cell 64, 281-302 (1991).
20. Sarkisian, C. J. et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nature Cell Biol. 9, 493-505 (2007).
21. Smallbone, K., Gatenby, R. A., Gillies, R., Maini, P. & Gavaghan, D. Metabolic changes during carcinogenesis: potential impact on invasiveness. J. Theor. Biol. 244, 703-713 (2007).
22. Rubin, H. Multistage carcinogenesis in cell culture. Dev. Biol. 106, 61-66 (2001).
23. Burger, A. M. et al. Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells. Int. J. Oncol. 19, 1043-1048 (1998).
24. Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K. & Gillies, R. J. Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors. Neoplasia 7, 324-330 (2005).
25. Gillies, R. J. & Gatenby, R. A. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev. 26, 311-317 (2007).
26. Park, H. J., Lyons, J. C., Ohtsubo, T. & Song, C. W. Acidic environment causes apoptosis by increasing caspase activity. Br. J. Cancer 80, 1892-1897 (1999).
27. Gatenby, R. A. & Gawlinski, E. T. A reaction-diffuse model of acid-mediated invasion of normal tissue by neoplastic tissue. Cancer Res. 56, 5745-5753 (1996).
28. Rohzin, J., Sameni, M., Ziegler, G. & Sloane, B. F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 54, 6517-6525 (1994).
29. Abbey, C. K. et al. In vivo PET imaging of progression of transformation in a mouse model of mammary neoplasia. Proc. Natl Acad. Sci. USA 101, 11438-11443 (2005).
30. Yasuda, S. et al. 18F-FDG PET detection of colonic adenomas. J. Nucl. Med. 42, 989-992 (2001).
31. Younes, M., Ertan, A., Lechago, L. V., Somoano, J. & Lechago, J. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Cancer Epidemiol. Biomarkers Prev. 6, 303-305 (1997).
32. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18 (2002).
33. Naumov, G. N. et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J. Natl Cancer Inst. 98, 316-325 (2006).
34. Giuriato, S. et al. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc. Natl Acad. Sci. USA 103, 16266-16271 (2006).
35. Gatenby, R. A. et al. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216-5223 (2006).